{
    "id": 28859,
    "fullName": "DEPTOR over exp",
    "impact": "none",
    "proteinEffect": "no effect",
    "geneVariantDescriptions": [
        {
            "description": "DEPTOR over exp indicates an over expression of the Deptor protein. However, the mechanism causing the over expression is unspecified.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 64798,
        "geneSymbol": "DEPTOR",
        "terms": [
            "DEPTOR",
            "DEP.6",
            "DEPDC6"
        ]
    },
    "variant": "over exp",
    "createDate": "10/24/2018",
    "updateDate": "10/24/2018",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 15111,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, docetaxel treatment of esophageal squamous cell carcinoma cells overexpressing Deptor were resistant to response as demonstrated by a lack in decreased cell viability (PMID: 28267437).",
            "molecularProfile": {
                "id": 30746,
                "profileName": "DEPTOR over exp"
            },
            "therapy": {
                "id": 720,
                "therapyName": "Docetaxel",
                "synonyms": null
            },
            "indication": {
                "id": 3748,
                "name": "esophagus squamous cell carcinoma",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 12647,
                    "pubMedId": 28267437,
                    "title": "Different functions of DEPTOR in modulating sensitivity to chemotherapy for esophageal squamous cell carcinoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28267437"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 15112,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, epirubicin treatment of esophageal squamous cell carcinoma cells overexpressing Deptor were resistant to response as demonstrated by a lack in decreased cell viability (PMID: 28267437).",
            "molecularProfile": {
                "id": 30746,
                "profileName": "DEPTOR over exp"
            },
            "therapy": {
                "id": 1013,
                "therapyName": "Epirubicin",
                "synonyms": null
            },
            "indication": {
                "id": 3748,
                "name": "esophagus squamous cell carcinoma",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 12647,
                    "pubMedId": 28267437,
                    "title": "Different functions of DEPTOR in modulating sensitivity to chemotherapy for esophageal squamous cell carcinoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28267437"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 30746,
            "profileName": "DEPTOR over exp",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}